BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 3121562)

  • 21. Synergistic cytotoxicity of recombinant human TNF and various anti-cancer drugs.
    Watanabe N; Niitsu Y; Yamauchi N; Ohtsuka Y; Sone H; Neda H; Maeda M; Urushizaki I
    Immunopharmacol Immunotoxicol; 1988; 10(1):117-27. PubMed ID: 2452179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of TNF-alpha, IL-1, and IFN-gamma against three human osteosarcoma cell lines.
    Jia SF; Kleinerman ES
    Lymphokine Cytokine Res; 1991 Aug; 10(4):281-4. PubMed ID: 1932372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic enhancement of the antitumor activity of recombinant human TNF-alpha by recombinant human IFN-gamma.
    Taguchi T; Abe S; Nakano K; Matsui Y; Sohmura Y
    Cancer Detect Prev; 1988; 12(1-6):105-14. PubMed ID: 3141050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potential of natural human tumor necrosis factor-alpha in combination with natural human interferon-alpha or -gamma on human cancer cells.
    Shiiki S; Fuchimoto S; Orita K
    Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):345-51. PubMed ID: 3141998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro anti-proliferative effects of some anti-tumour drugs on feline mammary tumour cell lines.
    Muleya JS; Nakaichi M; Taura Y; Yamaguchi R; Nakama S
    Res Vet Sci; 1999 Jun; 66(3):169-74. PubMed ID: 10333454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
    J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combination of gamma-interferon and tumor necrosis factor causes a rapid and extensive differentiation of human neuroblastoma cells.
    Ponzoni M; Casalaro A; Lanciotti M; Montaldo PG; Cornaglia-Ferraris P
    Cancer Res; 1992 Feb; 52(4):931-9. PubMed ID: 1371090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of a human salivary gland cell line.
    Wu AJ; Kurrasch RH; Katz J; Fox PC; Baum BJ; Atkinson JC
    J Cell Physiol; 1994 Nov; 161(2):217-26. PubMed ID: 7962105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.
    Schiller JH; Groveman DS; Schmid SM; Willson JK; Cummings KB; Borden EC
    Cancer Res; 1986 Feb; 46(2):483-8. PubMed ID: 2416427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic cytotoxic effects of tumor necrosis factor, interferon-gamma and tamoxifen on breast cancer cell lines.
    Matsuo S; Takano S; Yamashita J; Ogawa M
    Anticancer Res; 1992; 12(5):1575-9. PubMed ID: 1444224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors.
    Kost ER; Mutch DG; Herzog TJ
    Gynecol Oncol; 1999 Mar; 72(3):392-401. PubMed ID: 10053112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic antitumor effects of natural human tumor necrosis factor-alpha and natural human interferon-alpha or -gamma on human cancer cell lines.
    Shiiki S; Fuchimoto S; Orita K
    Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):87-97. PubMed ID: 2501839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic induction of polypeptides by tumor necrosis factor and interferon-gamma in cells sensitive or resistant to tumor necrosis factor: assessment by computer based analysis of two-dimensional gels using the PDQUEST system.
    Beresini MH; Sugarman BJ; Shepard HM; Epstein LB
    Electrophoresis; 1990 Mar; 11(3):232-41. PubMed ID: 2111772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons.
    Vita JR; Edwalds GM; Gorey T; Housepian EM; Fetell MR; Guarini L; Langer JA; Fisher PB
    Anticancer Res; 1988; 8(3):297-302. PubMed ID: 2839097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death.
    Selleri C; Sato T; Anderson S; Young NS; Maciejewski JP
    J Cell Physiol; 1995 Dec; 165(3):538-46. PubMed ID: 7593233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins.
    Morimoto H; Yonehara S; Bonavida B
    Cancer Res; 1993 Jun; 53(11):2591-6. PubMed ID: 7684321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined effect of 5-fluorouracil and recombinant tumor necrosis factor against human gastric carcinoma cell lines.
    Li Y; Ito S; Cheng W; Ishii Y
    Anticancer Res; 1996; 16(4A):1771-4. PubMed ID: 8712699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the natural killer cell activity of human nonadherent mononuclear cells (nMNC) with tumor necrosis factor, interleukin-1, interferon-gamma and cisplatin.
    Pai K; Sodhi A
    Neoplasma; 1992; 39(6):363-7. PubMed ID: 1491726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis of cultured mouse luteal cells induced by tumor necrosis factor-alpha and interferon-gamma.
    Jo T; Tomiyama T; Ohashi K; Saji F; Tanizawa O; Ozaki M; Yamamoto R; Yamamoto T; Nishizawa Y; Terada N
    Anat Rec; 1995 Jan; 241(1):70-6. PubMed ID: 7879925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines.
    Morikage T; Ohmori T; Nishio K; Fujiwara Y; Takeda Y; Saijo N
    Cancer Res; 1993 Jul; 53(14):3302-7. PubMed ID: 8391922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.